BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
91.08
+0.89 (0.99%)
Jun 23, 2026, 1:28 PM EDT - Market open
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $23.03 billion as of June 23, 2026. Its market cap has decreased by -11.69% in one year.
Market Cap
23.03B
Enterprise Value
7.50B
1-Year Change
-11.69%
Ranking
Category
Stock Price
$91.08
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $23.03B, an increase of 669.04%. That is a compound annual growth rate of 35.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 23.03B | 0.62% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alnylam Pharmaceuticals | 37.13B |
| Revolution Medicines | 34.65B |
| Royalty Pharma | 30.50B |
| BeOne Medicines AG | 30.03B |
| Moderna | 25.38B |
| Roivant Sciences | 22.61B |
| Insmed | 20.76B |
| Incyte | 19.62B |